Results
|
621.
|
|
|
622.
|
|
|
623.
|
|
|
624.
|
|
|
625.
|
|
|
626.
|
|
|
627.
|
|
|
628.
|
|
|
629.
|
|
|
630.
|
|
|
631.
|
|
|
632.
|
|
|
633.
|
PARP inhibition in BRCA2-mutated prostate cancer. [electronic resource] by
- Nientiedt, C
- Tolstov, Y
- Volckmar, A-L
- Endris, V
- Bonekamp, D
- Haberkorn, U
- Jäger, D
- Sültmann, H
- Stenzinger, A
- Hohenfellner, M
- Grüllich, C
- Duensing, S
Producer: 20180501
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
634.
|
|
|
635.
|
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. [electronic resource] by
- Pujade-Lauraine, Eric
- Ledermann, Jonathan A
- Selle, Frédéric
- Gebski, Val
- Penson, Richard T
- Oza, Amit M
- Korach, Jacob
- Huzarski, Tomasz
- Poveda, Andrés
- Pignata, Sandro
- Friedlander, Michael
- Colombo, Nicoletta
- Harter, Philipp
- Fujiwara, Keiichi
- Ray-Coquard, Isabelle
- Banerjee, Susana
- Liu, Joyce
- Lowe, Elizabeth S
- Bloomfield, Ralph
- Pautier, Patricia
Producer: 20170925
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
636.
|
|
|
637.
|
|
|
638.
|
|
|
639.
|
|
|
640.
|
|